• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550250-12
Medical Device Problem Codes Device Dislodged or Dislocated (2923); Migration (4003)
Health Effect - Clinical Code Foreign Body In Patient (2687)
Date of Event 12/17/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Medwatch mw5098703.The device is not returning for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
User facility medwatch report received [mw5098703] that states: [while placing xience stent, stent displaced and required snare to retrieve.Patient was undergoing left heart cath with stent placement.] additional reported information was received from the account reporting that the target lesion was 100% stenosed in the left posterior descending artery.A 2.5x12 xience sierra stent delivery system was advanced without resistance; however, the stent completely dislodged off the balloon inside the patient's anatomy.A snare device was attempted but the stent was not retrieved.The stent was then deployed in the mid circumflex artery but migrated and was ultimately deployed in the proximal circumflex.The procedure was completed with percutaneous transluminal coronary angioplasty only.There were no reported adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.As there was no damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that interaction with the 100% stenosed anatomy and/or other devices resulted in compromising the stent and ultimately resulted in the reported stent dislodgement and migration.The treatment(s) appears to be related to the operational context of the procedure as an unsuccessful attempt was made to snare the dislodged stent.The stent was then deployed in the mid circumflex artery but migrated and was ultimately deployed in the proximal circumflex.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11369331
Report Number2024168-2021-01402
Device Sequence Number3781948
Product Code NIQ
UDI-Device Identifier08717648227080
UDI-Public08717648227080
Combination Product (Y/N)Y
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source health professional,user faci
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/17/2022
Device Model Number1550250-12
Device Catalogue Number1550250-12
Device Lot Number0111141
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/01/2021
Supplement Date Received by Manufacturer02/25/2021
Initial Report FDA Received Date02/23/2021
Supplement Report FDA Received Date03/03/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age59 YR
Patient Weight89
-
-